In some ways, data and its quality can seem strange to people used to assessing the quality of software. There’s often no observable behaviour to check and little in the way of structure to help you ...
A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Illumina became a genomics juggernaut by developing machines that could read large ...
Hope Biosciences has linked its stem cell therapy candidate to improved motor function in Parkinson’s disease patients in a phase 2 trial. The single-site study randomized 60 people with early to ...
EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a ...
The US government is beginning to grow cautious of AI data centers (AIDCs) because of their enormous pressure on power grids. In facing the hard limits of energy resources, policymakers will be forced ...
At its annual Ecosystem Day on December 12, Hithium Energy Storage signaled a strategic improvement beyond conventional four-hour batteries, positioning long-duration storage as both a grid asset and ...
Researchers at the Keck School of Medicine of University of Southern California (USC) have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response ...
PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Striim, a global leader in real-time data intelligence for enterprise AI, today announced Validata , a new product for data validation and ...
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager, ALETA-001 Preliminary findings include a ...
Qihan Biotech Presents New Clinical Data on Allogeneic CAR-T Cell Therapies and Preclinical Data on In Vivo CAR-T at the American Society of Hematology (ASH) Annual Meeting – Clinical data from ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results